Evaluation of Patients With Known or Suspected Heart Disease
|ClinicalTrials.gov Identifier: NCT00001313|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : July 2, 2017
In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI).
Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test.
These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.
|Condition or disease|
|Peripheral Artery Disease Coronary Disease Diabetes and Heart Failure Dilated Cardiomyopathy Heart Failure Renal Artery Stenosis Pulmonary Hypertension|
|Study Type :||Observational|
|Official Title:||Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)|
|Study Start Date :||May 10, 1992|
|Study Completion Date :||January 6, 2009|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001313
|United States, Maryland|
|Bethesda, Maryland, United States, 20814|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|